PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 3683592-7 1987 The extraneuronal MAO activity was low for all three catecholamines, (-)-adrenaline, (-)-noradrenaline and dopamine (range of kMAO from 0.05 to 0.28 min-1) and declined in the order. Epinephrine 69-83 monoamine oxidase A Rattus norvegicus 18-21 1407001-1 1992 The uptake and subsequent metabolism by catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO) of dopamine, adrenaline, isoprenaline and noradrenaline in isolated perfused lungs of rats has been examined. Epinephrine 117-127 monoamine oxidase A Rattus norvegicus 99-102 1407001-2 1992 In lung preparations in which COMT and MAO were inhibited, the uptake of 3H-labelled dopamine, (-)-adrenaline and (-)-noradrenaline, but not (+/-)-isoprenaline, was reduced by cocaine (10 or 100 mumol/l). Epinephrine 95-109 monoamine oxidase A Rattus norvegicus 39-42 1407001-8 1992 If dopamine or adrenaline are perfused through the pulmonary circulation in isolated lungs of the rat, they are taken up and then metabolized by COMT and MAO, as also occurs for noradrenaline. Epinephrine 15-25 monoamine oxidase A Rattus norvegicus 154-157 2446707-4 1987 Administration of the alpha 2-adrenoceptor antagonist idazoxan and the MAO inhibitor tranylcypromine elicited increases in hypothalamic extracellular levels of both adrenaline and noradrenaline by 208% and 229%, respectively. Epinephrine 165-175 monoamine oxidase A Rattus norvegicus 71-74 3319049-7 1987 The balance of norepinephrine to epinephrine found in vesicles in these terminals would be a function of intraneuronal PNMT activity, MAO activity and reuptake which would be the major regulator of intraneuronal norepinephrine concentrations. Epinephrine 18-29 monoamine oxidase A Rattus norvegicus 134-137 2411347-2 1985 Epinephrine concentrations were increased from 350 to 500% following chronic administration of LY 51641, a selective inhibitor of MAO type A. Epinephrine 0-11 monoamine oxidase A Rattus norvegicus 130-133 2411347-4 1985 The marked relative accumulation of epinephrine may be related to the efficacy of inhibitors of MAO type A in the treatment of depression. Epinephrine 36-47 monoamine oxidase A Rattus norvegicus 96-99 1090438-10 1975 The potentiation of insulin release caused by two of the MAO inhibitors studied was abolished by addition of 1 muM epinephrine into the incubation medium. Epinephrine 115-126 monoamine oxidase A Rattus norvegicus 57-60 7244360-0 1981 Elevation of epinephrine concentration in rat brain by LY51641, a selective inhibitor of type A monoamine oxidase. Epinephrine 13-24 monoamine oxidase A Rattus norvegicus 96-113 7244360-2 1981 The inhibition of type A MAO was accompanied by an increase in epinephrine concentration in hypothalamus. Epinephrine 63-74 monoamine oxidase A Rattus norvegicus 25-28 7244360-7 1981 Two analogs of LY51641 of differing selectivity elevated epinephrine concentration to a degree related to percentage inhibition of type A MAO, and the effect of LY51641 was antagonized by pretreatment with harmaline, a short-acting reversible inhibitor of type A MAO. Epinephrine 57-68 monoamine oxidase A Rattus norvegicus 138-141 7244360-8 1981 These findings support earlier evidence that in rat hypothalamus, epinephrine oxidation occurs by type A not type B MAO. Epinephrine 66-77 monoamine oxidase A Rattus norvegicus 116-119 1209687-9 1975 The results suggest that exogenous progesterone administration during late pregnancy increases epinephrine stores by declining monoamine metabolism by MAO and COMT and increasing their synthesis by PNMT which is responsible for N-methylation of norepinephrine to epinephrine. Epinephrine 95-106 monoamine oxidase A Rattus norvegicus 151-154 1244091-2 1975 MAO reaction inhibited by quinoline compound and the inhibition of kynurenine aminotransferase activity through the injection of epinephrine or serotonin were observed. Epinephrine 129-140 monoamine oxidase A Rattus norvegicus 0-3 6805416-3 1982 Epinephrine neuronal systems might play a part in some pharmacologic actions of MAO inhibitors and uptake inhibitors as well as alpha and beta agonists and antagonists. Epinephrine 0-11 monoamine oxidase A Rattus norvegicus 80-83 4445050-0 1974 The effect of the chronic L-adrenaline, D, L-metanephrine and L-thyroxine administration on the MAO activity in rat"s brain. Epinephrine 26-38 monoamine oxidase A Rattus norvegicus 96-99 11164826-1 2001 3,4-Dihydroxyphenylglycolaldehyde is the monoamine oxidase-A metabolite of two catecholamine neurotransmitters, epinephrine and norepinephrine. Epinephrine 112-123 monoamine oxidase A Rattus norvegicus 41-60 9237550-1 1997 3,4-Dihydroxyphenylglycolaldehyde (DOPEGAL) is the monoamine oxidase A metabolite of norepinephrine and epinephrine. Epinephrine 88-99 monoamine oxidase A Rattus norvegicus 51-70 9518674-1 1998 3,4-Dihydroxyphenylglycolaldehyde (DOPEGAL) is the monoamine oxidase A metabolite of norepinephrine (NE) and epinephrine. Epinephrine 88-99 monoamine oxidase A Rattus norvegicus 51-70 8138937-0 1994 Different metabolism of norepinephrine and epinephrine by catechol-O-methyltransferase and monoamine oxidase in rats. Epinephrine 27-38 monoamine oxidase A Rattus norvegicus 91-108 8216383-3 1993 The procedure is suitable for use with a wide range of MAO substrates, although 5-hydroxytryptamine, adrenaline and noradrenaline are too readily oxidized by hydrogen peroxide to be used. Epinephrine 101-111 monoamine oxidase A Rattus norvegicus 55-58 8813375-1 1996 3,4-Dihydroxyphenylglycolaldehyde (DOPEGAL) is the monoamine oxidase A (MAO-A) metabolite of norepinephrine (NE) and epinephrine (Epi). Epinephrine 96-107 monoamine oxidase A Rattus norvegicus 51-70 8813375-1 1996 3,4-Dihydroxyphenylglycolaldehyde (DOPEGAL) is the monoamine oxidase A (MAO-A) metabolite of norepinephrine (NE) and epinephrine (Epi). Epinephrine 96-107 monoamine oxidase A Rattus norvegicus 72-77